£280,000 cash injection for Conjunct

BRAVEHEART, the Aim-listed investment group, has led a funding round to pump £280,000 into a Livingston-based technology business.

Conjunct was launched in 2004 as a spin-out from Heriot-Watt University. It develops devices to transport large amounts of data around circuits using light instead of electrical signals.

Braveheart claims that Conjunct's Fibre-Lyte transceiver is the "smallest and most compact" in its market.

Scottish Enterprise's co- investment fund and LINC Scotland also injected cash.

Perth-based Braveheart said it first invested 300,000 in the firm in 2008.

"Since then, the company's product development has exceeded expectations and Conjunct now expects to have a 40Gb product available for trials with a number of potential customers this year," it added.

Ken Allstaff, Conjunct's chief executive, said: "This additional funding will allow us to bring Fibre-Lyte to a market which is driven by the insatiable internet, whose users continue to grow and who demand ever-increasing data rates."